DK1267885T3 - Formulering til svangerskabsforebyggelse hos mænd, hvilken formulering indeholder norethisteron og testoteronundecanoat - Google Patents

Formulering til svangerskabsforebyggelse hos mænd, hvilken formulering indeholder norethisteron og testoteronundecanoat

Info

Publication number
DK1267885T3
DK1267885T3 DK01902590T DK01902590T DK1267885T3 DK 1267885 T3 DK1267885 T3 DK 1267885T3 DK 01902590 T DK01902590 T DK 01902590T DK 01902590 T DK01902590 T DK 01902590T DK 1267885 T3 DK1267885 T3 DK 1267885T3
Authority
DK
Denmark
Prior art keywords
norethisterone
formulation
undecanoate
contraception
testoterone
Prior art date
Application number
DK01902590T
Other languages
Danish (da)
English (en)
Inventor
Eberhard Nieschlag
Axel Kamischke
Michael Oettel
Alexander Ruebig
Ekkerhard Schillinger
Ursula-Friederike Habenicht
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Application granted granted Critical
Publication of DK1267885T3 publication Critical patent/DK1267885T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK01902590T 2000-02-15 2001-02-15 Formulering til svangerskabsforebyggelse hos mænd, hvilken formulering indeholder norethisteron og testoteronundecanoat DK1267885T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50372900A 2000-02-15 2000-02-15
EP00200493 2000-02-15
PCT/IB2001/000188 WO2001060376A1 (fr) 2000-02-15 2001-02-15 Preparation contraceptive masculine comprenant de la norethistereone

Publications (1)

Publication Number Publication Date
DK1267885T3 true DK1267885T3 (da) 2007-07-09

Family

ID=26071832

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01902590T DK1267885T3 (da) 2000-02-15 2001-02-15 Formulering til svangerskabsforebyggelse hos mænd, hvilken formulering indeholder norethisteron og testoteronundecanoat

Country Status (26)

Country Link
EP (2) EP1267885B8 (fr)
JP (1) JP2003522795A (fr)
KR (1) KR20020086905A (fr)
CN (1) CN1423560A (fr)
AT (2) ATE355844T1 (fr)
AU (1) AU2001230447A1 (fr)
BG (1) BG107066A (fr)
BR (1) BR0108411A (fr)
CA (1) CA2398063A1 (fr)
CY (1) CY1106639T1 (fr)
CZ (1) CZ20022691A3 (fr)
DE (2) DE60142647D1 (fr)
DK (1) DK1267885T3 (fr)
EE (1) EE200200454A (fr)
ES (1) ES2282230T3 (fr)
HK (1) HK1049442B (fr)
HU (1) HUP0300128A3 (fr)
IL (1) IL151219A0 (fr)
MX (1) MXPA02007675A (fr)
NO (1) NO20023607L (fr)
PL (1) PL357185A1 (fr)
PT (1) PT1267885E (fr)
RU (1) RU2002124602A (fr)
SI (1) SI1267885T1 (fr)
SK (1) SK11602002A3 (fr)
WO (1) WO2001060376A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10234525A1 (de) * 2002-07-25 2004-02-05 Schering Ag Zusammensetzung, enthaltend ein androgenes 11ß-Halogensteroid und ein Gestagen sowie männliches Kontrazeptivum auf Basis dieser Zusammensetzung
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
CA2492079C (fr) 2002-07-24 2012-01-10 Schering Aktiengesellschaft Procedes microbiologiques permettant de produire des 11 alpha-hydroxysteroides 7 alpha-substitues
WO2004011008A1 (fr) * 2002-07-25 2004-02-05 Schering Aktiengesellschaft COMPOSITION CONTENANT UN 11β-HALOGENOSTEROIDE ANDROGENE ET UN GESTAGENE, ET CONTRACEPTIF MASCULIN A BASE DE CETTE COMPOSITION
CN101352443B (zh) * 2007-07-23 2011-01-12 中国科学院动物研究所 哺乳动物雄性不育剂
IL277372B2 (en) 2018-03-23 2023-09-01 Laboratoires Major Non-hormonal preparations including (r)-silodosin and male contraceptive methods, including once-daily administration of (r)-silodosin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714420A1 (de) * 1976-06-01 1977-12-08 Int Pregnancy Advisory Service Antikonzeptionsmittel zur verabreichung an mann und frau in einer gemeinsamen verabreichungspackung
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
US5035891A (en) 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
DE19650352A1 (de) * 1996-12-04 1998-07-30 Jenapharm Gmbh Oral wirksames Kombinationspräparat zur Kontrazeption für den Mann

Also Published As

Publication number Publication date
EP1666044B1 (fr) 2010-07-21
DE60142647D1 (de) 2010-09-02
CA2398063A1 (fr) 2001-08-23
HUP0300128A2 (en) 2003-05-28
IL151219A0 (en) 2003-04-10
ES2282230T3 (es) 2007-10-16
JP2003522795A (ja) 2003-07-29
KR20020086905A (ko) 2002-11-20
DE60127103D1 (de) 2007-04-19
EP1267885B8 (fr) 2007-06-20
HK1049442B (zh) 2007-06-15
HUP0300128A3 (en) 2004-03-29
ATE355844T1 (de) 2007-03-15
EP1267885A1 (fr) 2003-01-02
RU2002124602A (ru) 2004-03-10
PT1267885E (pt) 2007-05-31
CZ20022691A3 (cs) 2003-01-15
DE60127103T2 (de) 2007-11-22
CN1423560A (zh) 2003-06-11
SI1267885T1 (sl) 2007-08-31
BR0108411A (pt) 2003-03-11
WO2001060376A1 (fr) 2001-08-23
NO20023607D0 (no) 2002-07-30
NO20023607L (no) 2002-10-15
BG107066A (en) 2003-05-30
EP1267885B1 (fr) 2007-03-07
SK11602002A3 (sk) 2003-03-04
HK1049442A1 (en) 2003-05-16
CY1106639T1 (el) 2012-01-25
ATE474580T1 (de) 2010-08-15
EP1666044A1 (fr) 2006-06-07
EE200200454A (et) 2003-12-15
MXPA02007675A (es) 2004-02-26
AU2001230447A1 (en) 2001-08-27
PL357185A1 (en) 2004-07-26

Similar Documents

Publication Publication Date Title
NO20032805D0 (no) Preparater av östrogensyklodekstrinkomplekser
CY1106639T1 (el) Τυποποιηση αντισυλληπτικου για ανδρες που περιλαμβανει νορεθιστερονη
HUP9900301A2 (hu) Hormontapasz
DE59510887D1 (de) Feste arzneiformen, enthaltend clathrate vom steroidalen sexualhormon ethinylestradiol
AR073972A2 (es) Composiciones farmaceuticas para el tratamiento de carencias estrogenicas en la menopausia y para la prevencion de la osteoporosis en mujeres menopausicas
WO2001003687A3 (fr) Procede et compositions d'inhibition de la biosynthese ou de la bioactivite d'hormones sexuelles steroidiennes endogenes chez des sujets humains
DE59805902D1 (de) Nichtestrogene derivate des estradiols mit antioxidativer aktivität
ZA200201250B (en) Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11.
AR027526A1 (es) Formulacion anticonceptiva masculina que comprende noretisterona
EP1513588B1 (fr) Utilisation de nouveaux esters d'etonogestrel
JP2003522795A5 (fr)
PL360669A1 (en) 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
GB1060632A (en) Steroid compositions
ECSP034605A (es) Uso de antiprogestinas para la profilaxis y el tratamiento de enfermedades dependientes de hormonas
CO6270329A2 (es) Uso de gestageno en combinacion con un estrogeno y uno o varios excipientes / portadores farmaceuticamente acepptables para la anticoncepcion oral sin lactosa